Despite considerable evidence that neuronal activity influences the organization and function of circuits in the developing and adult brain, the molecular signals that translate activity into structural and functional changes in connections remain largely obscure. This review discusses the evidence implicating neurotrophins as molecular mediators of synaptic and morphological plasticity. Neurotrophins are attractive candidates for these roles because they and their receptors are expressed in areas of the brain that undergo plasticity, activity can regulate their levels and secretion, and they regulate both synaptic transmission and neuronal growth. Although numerous experiments show demonstrable effects of neurotrophins on synaptic plasticity, the rules and mechanisms by which they exert their effects remain intriguingly elusive.
INTRODUCTION
Particular spatial and temporal patterns of electrical activity, such as coincident activity in the pre-and postsynaptic neurons of a synapse (Hebb 1949) , are widely believed to regulate the efficacy of synaptic transmission. Such usedependent forms of synaptic plasticity encompass a wide range of structural and functional modifications covering timescales ranging from milliseconds to years. During development, patterns and levels of activity are believed to form 295 0147-006X/99/0301-0295$08.00 the basis of competition between different axons for postsynaptic targets by stabilizing and elaborating coincident inputs and weakening and removing noncoincident inputs (reviewed by Goodman & Shatz 1993 , Katz & Shatz 1996 . In the adult, particular patterns of coincident activity in presynaptic inputs and postsynaptic cells induce both short-and long-term synaptic changes, providing potential mechanisms for learning and memory (reviewed by Madison et al 1991 , O'Dell et al 1991 , Bailey & Kandel 1993 , Hawkins et al 1993 , Stevens 1993 , Malinow 1994 , Bear & Malenka 1994 , Larkman & Jack 1995 . A diverse set of molecular signals is presumably involved in translating these different patterns of activity into changes in synaptic connectivity and efficacy, but the identity of most such signals in the mammalian brain has remained obscure, especially on the longer timescale of days to years.
Recently, the neurotrophins have emerged as attractive candidates for such signaling molecules and have been proposed to play central roles in a variety of forms of synaptic plasticity (reviewed by Fox & Zahs 1994 , Lo 1995 , Thoenen 1995 , Bonhoeffer 1996 , Snider & Lichtman 1996 . The neurotrophins comprise a family of at least four structurally related proteins-nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4/neurotrophin-5 (NT-4/5)-that exert their effects through two classes of receptors, high-affinity tyrosine kinase receptors (Trk receptors) and a lower-affinity receptor, p75 (for reviews, see Bothwell 1991 , Chao 1992 , Meakin & Shooter 1992 , Barbacid 1994 , Dechant et al 1994 , Lindsay et al 1994 , Ip & Yancopolous 1996 , Segal & Greenberg 1996 . NGF, the prototypical member of this family, has been clearly defined as a target-derived trophic factor required for the survival of certain types of peripheral neurons; by extension, the other neurotrophins are thought to play similar roles for other neuronal populations, especially in the peripheral nervous system (PNS) (reviewed by Levi-Montalcini 1987 , Purves 1988 , Barde 1989 , Oppenheim 1991 , Davies 1994 , Snider 1994 , Bothwell 1995 , Lewin & Barde 1996 . This review will focus on evaluating evidence that neurotrophins, beyond their role as permissive survival factors, also mediate important forms of synaptic plasticity, particularly in the central nervous system (CNS). For comprehensive reviews of cellular mechanisms of synaptic plasticity, neurotrophin signal transduction, and other biological actions of neurotrophins, the reader is referred to numerous substantial reviews that have been published recently (e.g. Barde 1989 , Madison et al 1991 , Chao 1992 , Meakin & Shooter 1992 , Korsching 1993 , Stevens 1993 , Barbacid 1994 , Bear & Malenka 1994 , Heumann 1994 , Malinow 1994 , Bothwell 1995 , Larkman & Jack 1995 , Ip & Yancopolous 1996 , Lewin & Barde 1996 , Segal & Greenberg 1996 .
In order to play a meaningful role in synaptic plasticity, the neurotrophins must satisfy the following criteria:
1. Neurotrophins and their cognate receptors must be expressed in the right places and at the right times for the form of synaptic plasticity being considered.
2. Neurotrophin expression and secretion must be activity dependent.
3. Neurotrophins must regulate aspects of neuronal function that change activity in neural circuits, including synaptic function, membrane excitability, and neuronal morphology and connectivity.
The following sections will consider each of these requirements in turn.
NEUROTROPHINS AND THEIR RECEPTORS ARE PRESENT IN THE CENTRAL NERVOUS SYSTEM DURING PERIODS OF SYNAPTIC PLASTICITY
The first requirement for neurotrophins as molecular mediators of synaptic plasticity is that they be present in the relevant locations in the CNS during times of developmental or adult plasticity.
Distribution of Neurotrophins and Their Receptors
The expression of the neurotrophins and their receptors has been studied primarily at the mRNA level by in situ hybridization. BDNF, NT-3, and NT-4/5 and their receptors, TrkB and TrkC, are widely and specifically distributed in the CNS, whereas NGF expression is restricted to defined areas of the CNS such as striatal and basal forebrain cholinergic neurons (reviewed by Chao 1992 , Barbacid 1994 , Lindsay et al 1994 . BDNF and NT-3 and their cognate receptors, TrkB and TrkC, are particularly highly expressed in the cerebellum, hippocampus, and cerebral cortex, all well-studied sites of both developmental and adult synaptic plasticity. In situ hybridization studies further indicate that full-length, kinase-containing forms of TrkB and TrkC are expressed, and often coexpressed, on most CNS neurons but not on nonneuronal cells. In contrast, truncated, noncatalytic forms of both TrkB and TrkC are found in both neurons and glial cells (reviewed by Barbacid 1994 , Lindsay et al 1994 . In addition to their specific patterns of expression in the adult CNS, the neurotrophins and their receptors are developmentally regulated (reviewed by Davies 1994). BDNF, NT-3, and NT-4/5 mRNA levels increase in abundance with postnatal age (Maisonpierre et al 1990 , Friedman et al 1991 , Timmusk et al 1993a , and in rats, mRNA levels for TrkB and TrkC transiently peak between postnatal day 1 (P1) and P14 in several different brain regions, correlating with maximal neuronal growth, differentiation, and synaptogenesis (Ernfors et al 1990 , Dugich-Djordjevic et al 1992 , Ringstedt et al 1993 , Altar et al 1994 , Knusel et al 1994 . In the developing ferret visual system TrkB immunoreactivity increases specifically in separate locations at times of neuronal growth and synaptogenesis (Cabelli et al 1996) .
Although this specific spatial and temporal distribution of the neurotrophin and Trk receptors indicates that they are likely to be in the right place at the right time to be involved in both developmental and adult plasticity, many basic questions about their expression remain unanswered. First, there may not be a predictable relationship between mRNA and protein levels of neurotrophins; in fact, BDNF mRNA and protein have been shown to be regulated independently following seizure activity in the hippocampus (Wetmore et al 1994) and during visual system development in chickens (Johnson et al 1997) .
mRNA expression studies have been further complicated by the existence of multiple isoforms of each of the principal Trk receptors. For example, at least seven distinct trkB transcripts encoding both full-length and truncated TrkB receptors (Klein et al 1990a,b; Middlemas et al 1991) and multiple trkC transcripts, encoding at least three distinct kinase domain variants and truncated forms of TrkC (Valenzuela et al 1993 , Tsoulfas et al 1993 , have been identified in the CNS. Studies using antibodies to detect protein levels directly have also been problematic, especially for Trk receptors, since antibodies reliably specific for each Trk receptor isoform are just now becoming available.
Most methods available for neurotrophin localization to date also suffer from a lack of sufficient sensitivity. Neurotrophins are likely to be secreted in very small amounts, and only a few Trk receptors may be required for neurotrophin function, perhaps both beyond the level of detection with current technology. Such technical difficulties have particularly hampered progress in studying the subcellular localization of endogenous neurotrophins and their receptors, one of the most pressing issues in the field.
REGULATION OF NEUROTROPHINS BY ACTIVITY

Effects of Activity on Neurotrophin Expression
Regulation of neurotrophin mRNA expression by electrical and synaptic activity was first demonstrated in the hippocampus, where high basal levels of neurotrophins are present. NGF and BDNF mRNA levels are rapidly and potently upregulated by epileptiform activity in the hippocampus and cerebral cortex (Gall & Isackson 1989 , Zafra et al 1990 , Ernfors et al 1991 , Isackson et al 1991 , Dugich-Djordjevic et al 1992 . Similarly, neuromuscular activity strongly regulates NT-4/5 mRNA levels in skeletal muscle (Funakoshi et al 1995) . In the hippocampus, changes in BDNF mRNA levels are particularly dramatic, increasing by over sixfold in dentate granule cells within 30 min after seizure induction (Ernfors et al 1991) . Interestingly, similar manipulations reduce NT-3 expression (Castren et al 1993 , Elmer et al 1996 , Mudo et al 1996 .
Manipulations meant to mimic neuronal activity are particularly effective in regulating neurotrophin mRNA levels in dissociated neuronal cultures. Depolarization of cultured hippocampal neurons and cerebellar granule cells with glutamate receptor agonists or high potassium, for example, dramatically increases the levels of mRNAs encoding BDNF and NGF (Lu et al 1991; Zafra et al 1990 Zafra et al , 1991 Zafra et al , 1992 Berzaghi et al 1993; Berninger et al 1995; Bessho et al 1993; Lindholm et al 1994) . Conversely, BDNF and NGF levels are downregulated in the presence of γ -aminobutyric acid (GABA) through activation of GABA A receptors (Zafra et al 1991 (Zafra et al , 1992 Berzaghi et al 1993; Berninger et al 1995) . These treatments cause rapid changes in neurotrophin mRNA levels; for example, BDNF mRNA levels increase by greater than 10-fold within 3 h after stimulation with the non-NMDA receptor agonist, kainate (Zafra et al 1991) . This activity-dependence of BDNF expression involves only a subset of the multiple promoters that direct BDNF transcription and is dependent on calcium entry and the activation of the transcription factor CREB (Timmusk et al 1993b (Timmusk et al , 1995 Shieh et al 1998; Tao et al 1998) .
There are at least two major limitations to the studies described above. First, the relationship between changes in neurotrophin mRNA levels and actual changes in protein levels needs to be investigated; indeed, BDNF mRNA and protein levels are known to be regulated differently after kainate-induced seizures in the hippocampus (Wetmore et al 1994) . Thus, direct protein measurements in such experiments will be important. Second, most studies on activity-mediated neurotrophin regulation have used stimuli whose relationship to naturally occurring levels and patterns of synaptic activity are unknown. For example, there are major differences between the effects induced by depolarization or total elimination of "activity" (such as adding KC1 to a culture, or blocking all activity with tetrodotoxin) and those elicited by more physiological forms of activity, which revolve around circuitry-driven changes in the number and/or pattern of action potentials and synaptic events.
In this context, it is important that more physiological levels of activity have also been shown to strongly regulate neurotrophin mRNA levels. Induction of hippocampal long-term potentiation (LTP), for example, rapidly and selectively increases BDNF mRNA levels, with little or no effect on the other neurotrophins (Patterson et al 1992 , Castren et al 1993 , Dragunow et al 1993 ; similar increases in BDNF mRNA levels are seen after induction of long-term depression (LTD) in the cerebellum (Yuzaki et al 1994) . Large changes in the levels of physiological stimuli, such as light, also regulate the production of BDNF and TrkB in the visual system (Castren et al 1992 , Schoups et al 1995 , Bozzi et al 1995 , Rocamora et al 1996 . In future experiments, it will be desirable to use even more subtle and regional manipulations resembling those of natural patterns of neuronal activity to determine the full range of physiological relevance of such activity dependence.
Effects of Activity on Neurotrophin Secretion
Although neurotrophin secretion in the PNS is generally constitutive (Barth et al 1984) , recent evidence suggests that central neurons and muscle cells may release neurotrophins through activity-regulated release pathways (Blochl & Thoenen 1995 , Wang & Poo 1997 . Secretion of NGF from hippocampal slices and dissociated hippocampal neurons overexpressing NGF is increased by high potassium depolarization, glutamate, and acetylcholine (Blochl & Thoenen 1995 , 1996 . Similarly, BDNF secretion from BDNF-overexpressing dissociated hippocampal neurons is increased fivefold by depolarization (Goodman et al 1996) . Consistent with this suggestive evidence, endogenous BDNF in hippocampal neuron dendrites has been localized to dense-core vesicles, which are potentially capable of undergoing regulated release (Fawcett et al 1997 , Smith et al 1997 , Moller et al 1998 . Activity-dependent secretion of NT-4/5 from transfected myocytes has also been demonstrated functionally by Wang & Poo (1997) .
Despite such evidence, major deficits remain in our understanding of how neurotrophin expression and release are regulated. Many of the experiments described above have relied on overexpression of neurotrophins in dissociated cultures and release evoked by strong, nonphysiological stimuli such as chronic depolarization and neurotransmitter application. It will be important in future experiments to study directly the release of endogenous neurotrophins by more physiological stimuli.
REGULATION OF SYNAPTIC PLASTICITY BY NEUROTROPHINS
The efficacy of synaptic transmission can be modulated over a wide range of temporal scales, ranging from synaptic modulation on the order of seconds to minutes (e.g. paired-pulse facilitation and post-tetanic potentiation; reviewed by Zuker 1989) to alterations that persist for many hours (e.g. LTP in hippocampus or LTD in the cerebellum; reviewed by Madison et al 1991 , O'Dell et al 1991 , Hawkins et al 1993 , Stevens 1993 , Malinow 1994 , Bear & Malenka 1994 , Larkman & Jack 1995 , Lisberger 1998 , Stevens & Sullivan 1998 . Still longerlasting synaptic modifications over the time course of days to years presumably occur but remain poorly understood. Below, we consider some of the evidence implicating neurotrophins in plastic changes over a variety of these timescales.
Acute Effects of Neurotrophins on Synaptic Transmission
Key evidence for short-term modulation of synaptic transmission was provided by Lohof et al (1993) , who found strong effects of BDNF and NT-3 on synaptic transmission at developing Xenopus neuromuscular synapses in culture. Acute application of either BDNF or NT-3 to these cultures increases the frequency but not the amplitude of spontaneous synaptic currents (mEPSCs) and the amplitude of nerve-evoked excitatory postsynaptic currents (EPSCs) (Lohof et al 1993 , Wang et al 1995 . These effects are large (greater than sixfold increases for NT-3) and rapid (beginning within 5 min of neurotrophin application) and depend on the continued presence of neurotrophin. More recently, Wang & Poo (1997) have shown that activity-dependent NT-4/5 secretion from transfected myocytes enhances acetylcholine release from presynaptic neurons.
Similar phenomena have also been reported for other CNS neurons. BDNF and NT-4 rapidly enhance spontaneous synaptic activity in dissociated cultures of hippocampal neurons (Lessmann et al 1994; Levine et al 1995b Levine et al , 1996 , while NT-3 potentiates spontaneous activity in cultured cortical neurons (Kim et al 1994) . In biochemical measurements, NGF and BDNF enhance high potassiuminduced release of acetylcholine and glutamate from hippocampal synaptosomes (Knipper et al 1994) and BDNF increases the expression levels of several synaptic vesicle proteins (Takei et al 1997) and promotes phosphorylation of synapsin 1 (Jovanovic et al 1996) . Intriguingly, BDNF increases the phosphorylation of NMDA receptors (Suen et al 1997) and alters the functional properties of NMDA receptor channels (Jarvis et al 1997). Finally, neurotrophins can rapidly elevate intracellular calcium levels (Berninger et al 1993, Stoop & Poo 1996 , Canossa et al 1997 , Finkbeiner et al 1997 , Jarvis et al 1997 .
Neurotrophins also appear to affect several other aspects of synaptic transmission. BDNF influences neuropeptide expression in cortical neurons (Nawa et al 1993 (Nawa et al , 1994 Croll et al 1994) and in hippocampal interneurons (Marty et al 1996a,b) , enhances the GABAergic phenotype in striatal and cortical neurons (Mizuno et al 1994 , Widmer & Hefti 1994 , acutely inhibits GABAergic synaptic transmission in hippocampal slices (Tanaka et al 1997) , and affects activity-dependent regulation of GABAergic neurons in neocortical cultures (Rutherford et al 1997) . Finally, exogenous NGF and BDNF also cause rapid and long-lasting changes in stimulus-dependent activity in the adult cortex in vivo (Prakash et al 1996) .
In hippocampal slices, acute application of either BDNF or NT-3 potentiates synaptic transmission at Schaffer collateral/CA1 synapses but does not occlude LTP (Kang and Schuman 1995) , an effect that requires local protein synthesis (Kang & Schuman 1996) . Such potentiation is not seen in all cases (Figurov et al 1996 , Patterson et al 1996 , Tanaka et al 1997 , Huber et al 1998 , an inconsistency that may be associated with the mode of BDNF delivery (Kang et al 1996) . Similar effects have also been reported at other synapses in the hippocampus (Scharfman 1997 , Messaoudi et al 1998 , and BDNF and NGF both acutely potentiate excitatory transmission in visual cortex (Carmignoto et al 1997) .
Long-Term Potentiation and Depression
The activity dependence and high-level of expression of BDNF and NT-3 in the hippocampus have led several groups to study their potential involvement in LTP and LTD, two especially well-studied models of synaptic plasticity. Despite initial observations that the rapid effects of neurotrophins do not occlude LTP (Kang & Schuman 1995) , LTP induction at the hippocampal Schaffer collateral-CA1 synapse was found to be compromised in BDNF knockout mice (Korte et al 1995 , Patterson et al 1996 . These defects could be rescued either by transfection of hippocampal slices with a BDNF expressing adenovirus (Korte et al 1996) or by application of exogenous BDNF (Patterson et al 1996) . Moreover, in normal animals, inhibition of BDNF signaling with receptor bodies (TrkBIgGs) or antibodies attenuates LTP in adult hippocampal slices (Figurov et al 1996 , Kang et al 1997 , while BDNF enhances LTP in visual cortex (Akaneya et al 1997) .
One possible interpretation of these experiments is that BDNF signaling plays a permissive role in various aspects of hippocampal function including LTP. It would then be expected that augmenting BDNF, regardless of its effects on basal synaptic transmission, would not occlude synaptically induced LTP. A permissive role would also predict that either genetic or pharmacological blockade of BDNF should inhibit LTP, as has been observed. Further supporting this idea is the observation that exogenous BDNF promotes LTP in young hippocampal slices at ages when LTP is normally not inducible; it does so by improving the ability of presynaptic fibers to follow tetanic stimulation, consistent with a permissive role for BDNF (Figurov et al 1996) .
Recent studies have begun to investigate the role of neurotrophins in LTD (Bear & Malenka 1994 , Linden & Connor 1995 , Bear & Abraham 1996 . Induction of LTD in cerebellar slices increases the expression of BDNF (Yuzaki et al 1994) , and, in the visual cortex, the induction of LTD by low-frequency stimulation is prevented by pretreatment with BDNF (Akaneya et al 1996, Huber et al 1998).
Neuronal Excitability
Membrane excitability is a major determinant of the intrinsic electrical properties of neurons and is a key aspect of neuronal function involved in neuronal plasticity in both development and maturity. It also represents, along with neurite outgrowth, one of the most well-known regulatory targets of NGF. The robust effects of NGF on intrinsic electrical excitability have been studied since the mid-1970s; most of this work has been carried out with PC12 cells and has focused on the expression levels of voltage-gated sodium and calcium currents (e.g. Greene & Tischler 1976; Dichter et al 1977; Rudy et al 1982 Rudy et al , 1987 O'Lague et al 1985; Streit & Lux 1987; Garber et al 1989; Kalman et al 1990; Pollock et al 1990; Usowicz et al 1990; Baev et al 1992; Pollock & Rane 1996; Sherwood et al 1997) . The regulation of voltage-gated sodium channels is known to be subtype specific and to occur at the transcriptional level (Mandel et al 1988 , D'Arcangelo et al 1993 , Toledo-Aral et al 1995 . Similar regulation of voltage-gated sodium and calcium channels by NGF has been found in neurons and skeletal muscle (Cooperman et al 1987 , Levine et al 1995a , Toledo-Aral et al 1997 . Finally, NGF and other neurotrophic factors also regulate voltage-gated potassium channel expression (Sharma et al 1993 , Dourado & Dryer 1994 , Timpe & Fantl 1994 , Lesser & Lo 1995 , Bowlby et al 1997 .
Studies of the influence of other neurotrophins on ion channel expression have provided an avenue for distinguishing between permissive and instructive effects of neurotrophin action on electrical excitability. In SK-N-SH neuroblastoma cells, each neurotrophin increases the expression of unique subsets of the ion channels normally expressed in these cells (Lesser et al 1997) . Although each neurotrophin activates initial signal transduction cascades to equivalent levels, each neurotrophin elicits a dramatically different end result on excitability. While NGF increases ion channel density similarly for all voltage-gated ion channels, BDNF and NT-3 have different and opposite effects on ion channel expression: BDNF increases excitability by selectively elevating sodium and calcium channel expression, while NT-3 decreases excitability by selectively elevating potassium channel expression. The unique effect of each neurotrophin on electrical excitability is consistent with an instructive role for neurotrophins in regulating this aspect of neuronal function.
Results such as these strongly imply a central role for neurotrophic factors in regulating electrical excitability, but a major limitation is that most of the experiments discussed above have been done with neuronal cell lines. It will be important that similar experiments be carried out with functional neural circuits and intact neural tissue to determine directly the functional consequences of trophic regulation of ion channel expression.
NEUROTROPHINS AND STRUCTURAL SYNAPTIC PLASTICITY
Structural changes in axonal and dendritic arbors are a hallmark of plastic rearrangements in developing systems; these lead to significant changes in the number and locations of functional synapses (Katz & Shatz 1996) . For example, the activity-driven rearrangements that result in eye-specific layers in the visual thalamus (Shatz 1983 , Linden et al 1981 , Sretavan & Shatz 1986 , Penn et al 1998 and ocular dominance columns in visual cortex (Hubel & Wiesel 1970 ; reviewed by Shatz 1990 , Katz & Shatz 1996 involve the elaboration of synapses in one layer or column and the loss of synapses in other layers or columns. Local rearrangements on smaller scales have been implicated in plastic changes in the adult nervous system, such as lesion-induced plasticity in adult visual and somatosensory cortices (reviewed by Merzenich et al 1990 , Gilbert et al 1996 . Molecular signals that influence synaptic rearrangements should not only be able to modulate neuronal physiological properties but also be able to regulate the structure of axonal or dendritic arborizations (Bailey & Kandel 1993) .
Neurotrophins seem especially well suited to be involved in such structural changes. In fact, NGF was isolated by its ability to stimulate neurite growth: Addition of an NGF-secreting sarcoma to an explant of chicken sensory ganglion results in the emergence of a dramatic halo of neurites in only 12 h (LeviMontalcini et al 1954). Subsequently, each neurotrophin has been demonstrated to stimulate neurite outgrowth of specific populations of neurons in the PNS in vitro and in vivo (reviewed by Thoenen 1991 , Eide et al 1993 , Lindsay et al 1994 , Snider 1994 . Recent studies have started to define more precisely the nature and extent of these neurotrophin effects on axon pathfinding and dendritic growth in the CNS.
Axonal Branching and Rearrangements
Neurotrophins can exert both tropic and trophic influences on axons. Although both in vivo and in vitro experiments demonstrate that gradients of neurotrophins can exert chemotropic guidance of axons (Menesini Chen et al 1978; Gunderson & Barrett 1979; Campenot 1982a,b; Ming et al 1997; Song et al 1997) , this may be a function of neurotrophins only in some cases. For example, NGF clearly does not play a role in guiding axons to their targets in development of trigeminal neurons, since NGF receptors are first detected on trigeminal neurons after their axons reach their targets (Davies 1990) . Furthermore, the phenotypes of neurotrophin knockout mice (reviewed by Snider 1994) do not manifest predictable deficits in axon pathfinding as they do for other known chemotropic molecules (see, for example, Serafini et al 1996) .
However, independent of their chemotropic effects, neurotrophins can potently influence the complexity of axonal arbors both in vitro and in vivo in the CNS. In vitro application of BDNF, NT-3, and NT-4/5, but not NGF, enhances axonal arborization of retinal axons cocultured with optic tecta from the chicken (Inoue & Sanes 1997). In vivo infusion of BDNF, but not other neurotrophins, into the optic tectum of Xenopus tadpoles elicits substantial increases in the branching and complexity of retinal ganglion cell axons (Cohen-Cory & Fraser 1995) . These effects are rapid (within 2 h) and persist for at least 24 h. Conversely, injection of antibodies to BDNF prevents axon growth and reduces axon complexity (Cohen-Cory & Fraser 1995).
Neurotrophins and the Control of Dendritic Form
The bulk of the brain's neuropil is composed of dendrites. The location, branching pattern, and morphological specializations of dendrites (spines, for example) are modified by activity and experience. Neurotrophins play a central role in sculpting and modifying dendrites, both in the PNS and, as more recent findings have shown, in the CNS.
Neurotrophins were first demonstrated to regulate dendritic growth in the PNS in an elegant series of experiments by Snider and colleagues (e.g. Snider 1988 , Purves et al 1988 , Ruit et al 1990 , Ruit & Snider 1991 . Systemic treatment of neonatal and adult rats with NGF for 1-2 weeks results in a dramatic expansion of dendritic arbors of sympathetic ganglion cells (Snider 1988 , Ruit et al 1990 . Conversely, injections of NGF antiserum in adult rats decrease the dendritic length of sympathetic neurons (Ruit & Snider 1991) .
In the CNS, neurotrophins regulate the dendritic growth of pyramidal neurons in the developing neocortex (McAllister et al 1995 , Baker et al 1998 . For example, each of the four neurotrophins, when applied to organotypic cortical slices for only 36 h, rapidly increases the length and complexity of dendrites of cortical pyramidal neurons (McAllister et al 1995) . Neurons in each cortical layer respond to subsets of neurotrophins with distinct effects on basal and apical dendrites, and, within a single cortical layer, each neurotrophin elicits a unique pattern of dendritic changes (McAllister et al 1995) . The specificity of these effects suggests that neurotrophins do not act simply to enhance neuronal growth but, rather, act instructively to modulate particular patterns of dendritic arborization.
One criticism of these and similar experiments, in which relatively high levels of an exogenous factor are applied to a system, is that any phenomena produced by this manipulation may not reflect the normal levels or spatial distribution of endogenous signaling molecules. Therefore, it is especially important to assess whether endogenous neurotrophins can also regulate dendritic growth. Experiments involving Trk "receptor bodies" (Shelton et al 1995) , which are fusion proteins of the ligand-binding domains of each Trk receptor and the Fc domain of human IgG, clearly demonstrate that removing endogenous neurotrophins has dramatic consequences for the dendritic growth of pyramidal neurons in developing cortex (McAllister et al 1997) . Consistent with the results of adding exogenous factors, endogenous BDNF is required for the growth and maintenance of dendritic arbors of layer 4 neurons whereas endogenous NT-3 is required for the growth and maintenance of dendritic arbors of layer 6 neurons.
Removing endogenous neurotrophins also reveals an added level of regulation not apparent from experiments in which exogenous factors were added. Endogenous BDNF (or possibly NT-4/5) and NT-3 oppose one another in regulating dendritic growth: in layer 4, NT-3 limits dendritic growth caused by BDNF, while in layer 6, BDNF inhibits dendritic growth stimulated by NT-3 (McAllister et al 1997) . Thus, while neurotrophins have classically been considered to act as growth-promoting molecules, it appears that they can also act to inhibit dendritic growth. The opposing roles of these two factors suggest that the well-documented overlap in neurotrophin signaling systems (e.g. the colocalization of TrkB and TrkC and their respective ligands; see Lindsay et al 1994 for a review) may not represent simple redundancy but, rather, may represent the outline of a tightly regulated system for modulating dendritic growth.
Synapse Number, Size, and Maturity
In addition to regulating the size of presynaptic terminal arbors and the extent of postsynaptic dendrites, target-derived neurotrophins have been widely hypothesized to regulate overall synapse number. This was first observed by Nja & Purves (1978) in the context of superior cervical ganglia, where manipulation of NGF levels regulated both the strength and number of preganglionic inputs. However, there are few other clear examples of direct effects of neurotrophins on synapse number. In one recent example involving transgenic mice selectively overexpressing BDNF in sympathetic neurons, electron microscopic counts of the synaptic innervation of sympathetic ganglia showed a two-to four-fold increase in synapse number; in BDNF knockout mice, synapse numbers were correspondingly decreased (Causing et al 1997) . Indirect evidence that neurotrophins influence the maturation of functional synapses comes from studies of the long-term effects of neurotrophins on synapses in Xenopus nerve-muscle cultures. BDNF and NT-3 but not NGF bias synaptic transmission and axon morphology toward more mature phenotypes (Wang et al 1995) . Furthermore, BDNF, NT-3, and NT-4/5 up-regulate neuregulin expression in rat spinal motor neurons, which promotes the maturation of neuromuscular synapses (Loeb & Fischbach 1997) .
CAN NEUROTROPHINS TRANSLATE NEURONAL ACTIVITY INTO PHYSIOLOGICAL AND STRUCTURAL PLASTICITY?
Segregation of axons from the lateral geniculate nucleus (LGN) into ocular dominance (OD) columns in layer 4 of the visual cortex and the manipulation of this process by selective visual experience has been a model system for studies of activity-dependent developmental plasticity (Hubel & Wiesel 1970) . The role of neurotrophins in activity-dependent competition during cortical development has been tested by using monocular deprivation during the critical period for OD development. When animals are deprived of vision in one eye during a critical period, the axons and cell bodies of cortical projecting neurons in the LGN shrink and neurons in the visual cortex become responsive to the nondeprived eye (see Wiesel 1982 for a review).
In early experiments, the physiological consequences of monocular deprivation in young rats were prevented by global application of NGF by infusion into the cerebral ventricles (Domenici et al 1991 (Domenici et al , 1993 Maffei et al 1992; Berardi et al 1993; Carmignoto et al 1993) ; conversely, anti-NGF antibodies were shown to disrupt normal visual system development (Berardi et al 1994 , Domenici et al 1994 . These findings led Maffei and colleagues to propose that axons from the LGN normally compete, in an activity-dependent manner, for a limiting supply of neurotrophin in layer 4 of the visual cortex. More recent experiments have shown that focal injection of latex beads coated with NT-4/5 but not those coated with BDNF, NT-3, or NGF into the visual cortex of monocularly deprived young ferrets prevents shrinkage of LGN neurons that project to the deprived cortex (Riddle et al 1995 (Riddle et al , 1997 . These results are also consistent with the hypothesis that LGN afferents compete in an activity-dependent manner for limiting quantities of a neurotrophin in cortical layer 4 but suggest that it is a TrkB ligand rather than NGF.
In recent experiments in which anatomical criteria were used to assess the development of OD columns, local infusion (via osmotic minipumps) of either BDNF or NT-4/5 but not NGF delayed or prevented the anatomical segregation of LGN afferents into OD patches (Cabelli et al 1995) . Similarly, infusion of TrkB-IgG fusion proteins, which remove endogenous BDNF or NT-4/5, but not of TrkA-IgG or TrkC-IgG also prevented segregation (Cabelli et al 1997) . One plausible interpretation of these experiments is that either adding or removing excess neurotrophin attenuates competition in layer 4 and thereby prevents segregation of LGN axons into OD columns (Cabelli et al 1997) .
Thus, although there is an emerging consensus that neurotrophins are, at some level, involved in the mechanisms of activity-dependent plasticity, there is considerable controversy about both the identity and the mode of action of the active neurotrophin. Earlier work by Maffei and colleagues stressed the role of NGF (see also Gu et al 1994), whereas subsequent findings from other laboratories have generally supported a role for TrkB ligands (either BDNF, NT-4/5, or both) (Cobelli et al 1995 (Cobelli et al , 1997 Riddle et al 1995 Riddle et al , 1997 Galuske et al 1996) . Part of the controversy presumably results from significant differences in choices of species, assays of effects, and methods of applying reagents.
For example, most of the work suggesting a role for NGF involved injections of reagents into the ventricles, which allows diffusion throughout large areas of the brain. In contrast, most of the results implicating TrkB ligands were obtained by more focal applications of neurotrophins or blockers. Both NGF and its receptor (TrkA) are expressed at very low levels, if at all, in the cortex (Merlio et al 1992 , Allendoerfer et al 1994 , Cabelli et al 1997 . One possible explanation of the NGF results is that NGF is acting on cholinergic neurons in the nucleus basalis, a structure rich in NGF and TrkA receptors, or their terminal arbors in the visual cortex, which also express TrkA receptors. However, it is also possible that TrkA is present at very low levels in cortical neurons.
Comparing results from different laboratories is also complicated by the very different measures of OD plasticity used. The bulk of the evidence for a role of NGF relies on electrophysiological assessments of OD, while the evidence for TrkB ligands (BDNF and NT-4/5) is largely anatomical. While some studies have integrated particular anatomical and physiological approaches (Carmignoto et al 1993 , Domenici et al 1993 , no study has yet used the full spectrum of electrophysiological and anatomical assays in a single well-defined model system.
CONCLUSIONS
The experiments reviewed here strongly suggest roles for neurotrophins in synaptic plasticity; however, the rules and mechanisms by which they work remain intriguingly elusive. Several critical issues will have to be resolved before hypotheses about neurotrophin function can be solidified. More thorough localization studies of the cellular and subcellular distribution of the neurotrophins and their receptors, as well as the locations and mechanisms of their secretion, are clearly needed to advance our understanding of the potential roles that neurotrophins might play in naturally occurring forms of synaptic plasticity. Such studies will be especially important in determining whether neurotrophins work through synapse-specific mechanisms, a cornerstone of many models of activity-dependent plasticity.
Two other important areas of investigation are discussed below.
Retrograde versus Anterograde Actions of Neurotrophins
Whether neurotrophins act in retrograde or anterograde directions (or both) has a clear impact on the specific forms of synaptic plasticity in which it is possible for them participate. The well-documented role of neurotrophins as targetderived, retrograde trophic factors in the PNS (Purves 1988 , Oppenheim 1996 , Snider 1994 ) has led many investigators to propose retrograde roles for neurotrophins in mediating synaptic plasticity in the CNS. Indeed, neurotrophins are retrogradely transported in both PNS and CNS neurons (Ernfors et al 1990 , DiStefano et al 1992 , Korsching 1993 , Campenot 1994 , Ehlers et al 1995 , Oppenheim 1996 , Bhattacharyya et al 1997 . However, other studies have shown substantial anterograde transport of neurotrophins in the CNS. Endogenous BDNF, for example, is prominently expressed in axon terminals, even in brain regions that lack BDNF mRNA, and inhibition of axonal transport or deafferentation depletes BDNF from these areas (Altar et al 1997 , Conner et al 1997 , Yan et al 1997 . Endogenous BDNF also appears to be anterogradely transported in primary sensory neurons (Zhou & Rush 1996 , Michael et al 1997 and exogenous NT-3, injected into the eyes of developing chickens, can act as an anterograde signal, being taken up by retinal ganglion cells and transported to axon terminals where it is then released and taken up by the dendrites of second-order visual neurons in the developing chicken brain (von Bartheld et al 1996) . BDNF protein is also increased in mossy fiber terminals in the hippocampus following seizure induction, specifically in a vesicular fraction associated with synaptic vesicles and dense core vesicles (Fawcett et al 1997 , Smith et al 1997 . This evidence, combined with several localization studies suggesting that TrkB is present in dendrites of neurons in both hippocampus and cortex (e.g. Fryer et al 1997 , Yan et al 1997 , makes an anterograde function for neurotrophins in synaptic plasticity at least as plausible as a retrograde function.
To complicate matters further, there is also increasing evidence for autocrine and paracrine roles of neurotrophins (Kokaia et al 1993 , Korsching 1993 , Miranda et al 1993 , Acheson & Lindsay 1996 , Davies 1996 , Marty et al 1996a . Activity-dependent survival of cortical neurons in culture, for example, has been shown to require the action of autocrine BDNF (Ghosh et al 1994) .
Spatial and Temporal Specificity of Neurotrophin Action
Direct roles for neurotrophins in synaptic plasticity require precise spatial and temporal regulation. Such specificity of action could be conferred temporally by activity-dependent secretion and spatially by secretion exclusively from synaptic sites or by a limited synaptic distribution of Trk receptors (Wetmore et al 1994 , Thoenen 1995 , Heymach et al 1996 , Tongiorgi et al 1997 , Moller et al 1998 . However, at present there is little direct evidence of such regulation for either neurotrophins or their receptors, as discussed above.
An alternative way to provide this specificity would be to require CNS neurons to be active in order to respond to neurotrophins, thereby allowing the timing and sites of activity to determine the temporal and spatial specificity of neurotrophin action. In support of this idea, pyramidal neurons in slices of developing visual cortex must be active in order to respond to BDNF; inhibiting action potentials, glutamatergic synaptic transmission, or L-type calcium channel activity blocks the otherwise dramatic increases in dendritic arborizations elicited by BDNF (McAllister et al 1996; but see Baker et al 1998) . Also, depolarizing agents enhance the survival-promoting and morphological effects of NGF on dissociated Purkinje cells (Cohen-Cory et al 1991) and those of BDNF and other neurotrophic factors on the survival and dissociated retinal ganglion cells (Meyer-Franke et al 1995) .
Resolving these and other issues remains a high priority for understanding how neurotrophins participate in various forms of synaptic plasticity. Nevertheless, it is exciting that we now have strong candidate molecular signals for mediating synaptic plasticity, especially over longer timescales that require changes in gene expression and neuronal connectivity. 
